Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study
Jordi Rodón, Mitchell Garrison(Wilford Hall Medical Center), Lisa A. Hammond(Institute of Clinical Cancer Research), Johann S. de Bono(Institute of Clinical Cancer Research), Lon Smith(Institute of Clinical Cancer Research), Leonardo Forero(Institute of Clinical Cancer Research), Desirée Hao(Institute of Clinical Cancer Research), Chris H. Takimoto(Institute of Clinical Cancer Research), John M. Lambert(ImmunoGen (United States)), Lini Pandite(GlaxoSmithKline (United States)), Maria Howard(ImmunoGen (United States)), Hongsheng Xie(ImmunoGen (United States)), Anthony W. Tolcher(Institute of Clinical Cancer Research)
Cited by 37
Abstract
Related Papers
No related papers found
Powered by citation graph analysis